Close
Nordic 9Nordic 9

Puhua Capital (investor - Venture Capital)

China puhuacapital.com
See something wrong or missing? Let us know
Offices:Hangzhou

Puhua Capital is a venture company from China.

Average round investment:70.75M USD
Average number per year:1.0
Distribution: 2025 (1)2024 (1)2022 (1)2021 (1)2020 (1)
Portfolio companies: United Kingdom bit.bioUnited Kingdom Ori BiotechUnited Kingdom Congenica
Mostly invests in: United Kingdom United Kingdom (5) Biotech (5)
See the entire list

Showing 3 of 5 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Puhua Capital mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Puhua Capital

Name Criteria
United States Fearless Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States National Resilience
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services, Competitive Intelligence
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Walden Catalyst Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Alex Gorsky
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services, Competitive Intelligence
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Brain Tumor Investment Fund
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Hercules Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Venture Science
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Norwest Venture Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services, Competitive Intelligence
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Belgium UCB Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Singapore EDBI
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Software Services, Competitive Intelligence
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Top